Memorial Sloan Kettering Cancer Center at Commack — Commack, New York

Memorial Sloan Kettering Cancer Center at Commack is a clinical research site located in Commack, New York, United States 11725.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloan Kettering Cancer Center at Commack has participated in 16 clinical trials with 4 currently active.

Therapeutic areas: Recurrent Brain Metastases, Progressive Brain Metastases, Head and Neck Cancer.

Sponsors: Memorial Sloan Kettering Cancer Center, Pfizer.

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan Kettering Cancer Center at Commack?

Memorial Sloan Kettering Cancer Center at Commack has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan Kettering Cancer Center at Commack conducted?

Memorial Sloan Kettering Cancer Center at Commack has 16 clinical trials on record, with 4 currently active. Their work covers Recurrent Brain Metastases, Progressive Brain Metastases, Head and Neck Cancer.

Is Memorial Sloan Kettering Cancer Center at Commack accredited by Crixeo Health?

Yes — Memorial Sloan Kettering Cancer Center at Commack holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Memorial Sloan Kettering Cancer Center at Commack?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.